ArticleMolecular therapy oncolytics2021

CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy.

Yi Chun Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.